Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionAviso Financial Inc.
Latest Disclosed Ownership808 shares
Latest Disclosed Value $ 29,694
Aviso Financial Inc. reports 81.17% decrease in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 13, 2026 - Aviso Financial Inc. filed a 13F-HR form disclosing ownership of 808 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $25,492 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 4,292 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of -81.17% during the quarter. The current value of the position is $28,943 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F NOVO-NORDISK A S ADR 670100205 808 -3,484 -81.17 30 -86.70 0.0011
2026-02-13 2025-12-31 13F NOVO-NORDISK A S ADR 670100205 4,292 -25,309 -85.50 218 -86.72 0.0083
2025-11-12 2025-09-30 13F NOVO-NORDISK A S ADR 670100205 29,601 -8,221 -21.74 1,643 -37.09 0.0668
2025-08-12 2025-06-30 13F NOVO-NORDISK A S ADR 670100205 37,822 702 1.89 2,610 1.28 0.1177
2025-05-13 2025-03-31 13F NOVO-NORDISK A S ADR 670100205 37,120 3,253 9.61 2,578 -11.53 0.1271
2025-02-10 2024-12-31 13F NOVO-NORDISK A S ADR 670100205 33,867 908 2.75 2,913 -25.76 0.1471
2024-11-13 2024-09-30 13F NOVO-NORDISK A S ADR 670100205 32,959 2,923 9.73 3,924 -8.47 0.1945
2024-08-14 2024-06-30 13F NOVO-NORDISK A S ADR 670100205 30,036 30,036 4,287 0.2389
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.